🇺🇸 FDA
Patent

US 12098118

Analgesic and anti-addictive compositions for treatment of chronic pain and opioid addiction

granted A61KA61K9/0019A61P

Quick answer

US patent 12098118 (Analgesic and anti-addictive compositions for treatment of chronic pain and opioid addiction) held by Regents of the University of Minnesota expires Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regents of the University of Minnesota
Grant date
Tue Sep 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K9/0019, A61P, A61P25/36, A61P29/00